Clinical Trial Update: A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and pharmacokinetics of GSK679586A when infused into healthy and mild asthmatic volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK679586A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED